All Updates

All Updates

icon
Filter
Partnerships
Caris Life Sciences partners with Flare Therapeutics to advance Flare’s precision oncology pipeline
Precision Medicine
Apr 13, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 13, 2023

Caris Life Sciences partners with Flare Therapeutics to advance Flare’s precision oncology pipeline

Partnerships

  • Molecular profiling company Caris Life Sciences has entered a multi-year strategic collaboration with drug discovery company Flare Therapeutics to speed up precision medicine approaches across five of Flare's therapeutic programs. Flare plans to leverage Caris’ solutions in its clinical trials to guide patient selection and participation. 

  • The collaboration will leverage Caris' molecular tissue and liquid profiling services, including whole-exome sequencing and whole-transcriptome sequencing for patients enrolled in Flare's clinical trials. Caris will also provide data insights and analytics capabilities to accelerate oncology drug discovery and identify novel biomarkers for Flare's pipeline. The partnership will allow Caris the first option to develop a companion diagnostic for any drug candidate developed as part of the collaboration.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.